Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2–4

BACKGROUND AND OBJECTIVES: CKD–mineral and bone disorders (CKD-MBD) measures contribute to cardiovascular morbidity in patients with CKD. Among these, fibroblast growth factor (FGF)-23 and its coreceptor Klotho may exert direct effects on vascular and myocardial tissues. Klotho exists in a membrane-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seiler, Sarah, Rogacev, Kyrill S., Roth, Heinz J., Shafein, Pagah, Emrich, Insa, Neuhaus, Stefan, Floege, Jürgen, Fliser, Danilo, Heine, Gunnar H.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2014
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046724/
https://ncbi.nlm.nih.gov/pubmed/24677555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07870713
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares